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Obesity is programmed in utero and small babies generally have small placentas. In some circumstances, an undernourished fetus
can expand its placental surface to extract more nutrients. We hypothesize that this results in an imbalanced nutrient supply to
the fetus leading to obesity. To determine whether placental size determines overweight and body composition, we studied 2003
subjects in adult life. Associations between placental surface area and indices of overweight were restricted to people who carried
the Pro12Pro genotype of the PPARγ2 gene. For every 1 SD increase in placental surface area, the odds ratio for overweight was
1.37 (95% CI 1.10 to 1.71; P = 0.005). Expansion of the placental surface in compensation for fetal undernutrition increases the
risk of overweight and a higher body fat percentage in people carrying the Pro12Pro genotype. We suggest that similar underlying
multifactorial mechanisms aﬀect the development of obesity in general.
1.Introduction
There is a body of evidence suggesting that type 2 diabetes
is programmed in utero [1, 2]. Fetal programming is the
process through which fetal malnutrition leads to lifelong
changes in the body organs and systems in ways that might
cause disease in later life [3]. There is some evidence that
obesity, a major risk factor for type 2 diabetes, is also
programmed in utero. Maternal hyperglycemia is associated
with obesity in the next generation [4, 5]. Women who
were in utero during the Dutch famine tended to be
overweight as adults as a consequence of early programming
[6]. Interestingly, animal experiments show that prenatal
undernutrition upregulates appetite [7].
Fetal nutrition depends on the placenta ability to trans-
port nutrients to the fetus from its mother [8]. This ability
is reﬂected in its size [9]. Small babies generally have small
placentas, but, in some circumstances, an undernourished
fetus can expand its placental surface to extract more
nutrients from the mother [10]. This phenomenon is well
known to sheep farmers who induce placental expansion by
undernourishing ewes in midgestation. When the ewes are2 International Journal of Pediatrics
returned to good pasture the expanded placenta results in
a larger fatter lamb than they otherwise would be. There
are ﬁndings suggesting that placental expansion occurs in
humans through extension of the placental surface along
its minor axis [11]. This is associated with long-term costs
that include hypertension. Interestingly, in sheep placental
expansion can only occur if the ewe was well nourished up
to the time of mating [12].
Maternal body size, especially height, can be used as a
marker of her life time nutrition. Short maternal stature
is a product of poor fetal and childhood nutrition, or
recurrent exposure to infections, and genetic factors [13].
Theperoxisome-proliferator-activatedreceptorγ2(PPARγ2)
gene encodes a nuclear hormone receptor that mediates
adipocyte diﬀerentiation and regulates glucose and lipid
metabolism [14–17]. Variants of the PPARγ2 have repeatedly
been linked to overweight, insulin resistance, and type
2 diabetes. Furthermore, PPARγ is known to play an
importantroleincontrollingplacentalvascularproliferation,
trophoblast diﬀerentiation, and invasion [18, 19].
We have previously shown that the association between
expansion of the placental surface with later hypertension
is dependent upon maternal height [11]. We now speculate
that the long-term costs could also include overweight and
obesity in later life. We therefore examined the long-term
eﬀects of placental expansions on overweight and body
composition taking maternal height and genetic factors, the
PPARγ2gene,intoaccount.WeexaminedthisintheHelsinki
Birth Cohort Study (HBCS), which comprises people born
in 1934–44 for whom the size of the placental surface was
measured at birth.
2. Patientsand Methods
The study cohort consists of 8760 men and women who were
born between 1934 and 1944 in Helsinki University Central
Hospital and who visited child welfare clinics in the city.
Details of the birth records and child welfare clinic records
have been described [20, 21]. The birth records included the
mother’s height. The weight and length of the baby at birth
were recorded, and we calculated the ponderal index (birth
weight/length3). The records also included the weight of the
placenta, together with the maximal so-called “diameter” of
thesurfaceandalesser“diameter”bisectingitatrightangles.
The diameters were measured because it was recognized that
the placental surface is more oval than circular and the two
diameters were used to describe this. Assuming an elliptical
surface, we estimated the surface area of the placenta as
maximal × lesser diameter ×π/4.
We used random number tables to select a sample of
people within the cohort who were still living in Finland.
In order to achieve a sample size in excess of 2000 people
we selected 2902 subjects and invited them to a clinic, 2003
visited the clinic. The procedures used at the clinic have been
described [21]. Written informed consent was obtained from
each subject before any procedures were carried out. The
Ethics Committee at the National Public Health Institute,
Finland, approved the study. At the clinic height and weight
were measured in light indoor clothing and without shoes
on. Body mass index (BMI) was calculated as weight (kg)
divided by height2 (m2). Estimates of total lean and fat mass
were measured by bioelectrical impedance analysis using the
InBody3.0eight-polartactileelectrodesystem,BiospaceCo.,
Ltd, Seoul, Republic of Korea, as described [22]. Details of
the genotyping procedure have been described previously
[23].
2.1. Statistical Methods. We analysed overweight using mul-
tiple logistic regression and percent body fat and lean body
mass using multiple linear regression. We always adjusted
for age and gender in these regressions. The measurements
of body and placental size were analysed as continuous
variables. Tests for interaction used the product of the
variables being studied.
3. Results
Table 1 shows the measurements of birth and placental
size and current body size, together with the frequency
of the Pro12Pro genotype. Table 2 shows the odds ratios
and regression coeﬃcients for three outcomes, overweight
(BMI ≥ 25kg/m2), body fat percentage, and lean body
mass, according to birth weight, ponderal index (birth
weight/length3), and placental size. The odds ratios and
regression coeﬃcients represent the change in each outcome
that is associated with a 1SD increase in birth size or
placental size. Lean body mass was predicted by each
measurement of body and placental size. Overweight was
predicted by high birth weight and high ponderal index,
while percent body fat was predicted by high ponderal index.
N e i t h e ro v e r w e i g h tn o rp e r c e n tb o d yf a tw a sp r e d i c t e db y
measurements of placental size.
As in previous analyses we divided the subjects around
the mother’s median height (160cm) (Table 3). In both
maternal height groups lean body mass was predicted by
all measurements of body and placental size. Among people
whose mothers were tall a long lesser placental diameter
predicted both overweight and percent body fat. There was
a statistically signiﬁcant interaction between the eﬀects of
mother’s height and the lesser diameter on percent body fat
(P for interaction = 0.02). Among people whose mothers
were short, no measurements of placental size predicted
overweight or percent body fat. Table 4 is therefore conﬁned
to people whose mothers’ were tall. The subjects are divided
according to their PPARγ2 genotype. Among carriers of the
Ala allele overweight was predicted by a large maximal diam-
eter but there were no other associations between placental
sizeandeitheroverweightorpercentbodyfat.Amongpeople
with the Pro12Pro genotype large placental area and a long
lesser diameter predicted both overweight and percent body
fat (Table 4). There were statistically signiﬁcant interactions
between the genotypes and the eﬀects of placental area and
the lesser diameter on overweight and percent body fat (P
for interaction = 0.004 and 0.05 for area and 0.03 and 0.09
for the lesser diameter, resp.). In people with the Pro12Pro
genotype a long maximal diameter predicted overweight but
not percent body fat. In a simultaneous regression with the
lesser diameter the maximal diameter no longer predictedInternational Journal of Pediatrics 3
Table 1: Measurements of size at birth and in adult life, and frequency of PPARγ2 genotype according to gender.
Males (n = 927) Females (n = 1075)
Mean St deviation Mean St deviation
Measurements at birth
Birth weight (g) 3476 500 3353 465
Placental weight (g) 655 124 643 120
Maximal placental diameter (cm) 19.5 2.3 19.3 2.2
Lesser placental diameter (cm) 17.0 2.2 16.8 2.2
Placental surface area (cm2) 262 58 257 58
Measurements in adult life
Age (years) 61.5 2.8 61.5 3.0
Height (cm) 176.8 6.0 163.2 5.7
Weight (kg) 86.2 14.3 73.8 13.8
Body mass index (BMI, kg/m2) 27.5 4.2 27.7 5.0
Body fat percentage (%) 23.8 6.0 33.9 6.9
Lean body mass (kg) 65.0 7.9 47.8 5.7
Overweight (BMI ≥ 25kg/m2, %) 74.0 67.7
PPARγ2g e n o t y p e
Pro/Pro (%) 68.5 67.9
Table 2:Oddsratios(95%conﬁdenceinterval)foroverweightandregressioncoeﬃcientsforpercentbodyfatandleanbodymassinrelation
to birth weight and placental size.
Overweight∗ Body fat (%)+ Lean body mass (kg)+
Birth weight (z) 1.13 (1.03 to 1.25) 0.03 (−0.26 to 0.32) 1.66 (1.36 to 1.95)
P for trend 0.01 0.8 <0.001
Ponderal index (z) 1.12 (1.01 to 1.23) 0.28 (−0.01 to 0.57) 0.40 (0.10 to 0.71)
P for trend 0.03 0.05 0.008
Placental weight (z) 1.07 (0.97 to 1.18) 0.02 (−0.28 to 0.31) 0.99 (0.69 to 1.29)
P for trend 0.2 0.9 <0.001
Max placental diam (z) 1.04 (0.94 to 1.14) 0.00 (−0.30 to 0.29) 0.64 (0.34 to 0.95)
p for trend 0.5 1.0 <0.001
Lesser placental diam (z) 1.07 (0.97 to 1.18) 0.09 (−0.20 to 0.39) 0.69 (0.39 to 1.00)
P for trend 0.2 0.5 <0.001
Placental area (z) 1.05 (0.95 to 1.15) 0.05 (−0.24 to 0.34) 0.69 (0.39 to 0.99)
P for trend 0.4 0.7 <0.001
∗Odds ratios from multiple logistic regressions, including age and gender, with overweight as outcome.
+Coeﬃcients from multiple linear regressions, including age and gender, with body fat percent or lean body mass as outcome.
overweight. The results in Table 4 were similar in men and
women.
4. Discussion
In the whole study sample placental size was not associated
with either overweight or a high percent of body fat. We
found, however, that an expanded placental surface and a
long lesser diameter predicted overweight and high percent
of body fat in a subset of men and women whose mothers
were tall and who carried the Pro12Pro genotype of the
PPARγ2 gene. Higher birth weight was associated with an
increased risk of having a BMI greater than 25kg/m2 and
with a greater lean body mass. This has been shown before
and suggests that birth weight inﬂuences adult body mass
index through its eﬀe c to nl e a nb o d ym a s s[ 22, 24]. Our
ﬁndings suggest that lean body mass is related to the volume
of placental tissue, reﬂected in its weight, while fat mass is
related to placental surface area.
We have previously shown that an enlarged placental
surface is associated with later hypertension, but this asso-
ciation was conﬁned to people whose mothers were tall [11].
We interpreted this as evidence that compensatory placental
expansion in humans is similar to compensatory expansion
in sheep, in that it can only occur in women who were well
nourished before they conceived. We have shown that people
whohadanenlargedplacentalsurfaceandlaterhypertension
had above-average birthweight [11]. This is consistent with
sheep farming practices in which placental expansion is
induced by undernourishing ewes [10, 12]. This leads to4 International Journal of Pediatrics
Table 3:Oddsratios(95%conﬁdenceinterval)foroverweightandregressioncoeﬃcientsforpercentbodyfatandleanbodymassinrelation
to birthweight and placental size, according to mother’s height. People whose mothers were >160cm are included in the table.
Overweight∗ Body fat (%)+ Lean body mass (kg)+
Birth weight (z) 1.18 (1.02 to 1.35) 0.02 (−0.39 to 0.43) 1.54 (1.15 to 1.93)
P for trend 0.02 0.9 <0.001
Ponderal index (z) 1.15 (1.00 to 1.32) 0.28 (−0.14 to 0.69) 0.41 (0.01 to 0.82)
P for trend 0.05 0.2 0.04
Placental weight (z) 1.06 (0.93 to 1.22) 0.15 (−0.26 to 0.56) 0.90 (0.51 to 1.29)
P for trend 0.4 0.5 <0.001
Max placental diam (z) 1.02 (0.89 to 1.16) −0.02 (−0.43 to 0.38) 0.45 (0.06 to 0.84)
P for trend 0.8 0.9 0.02
Lesser placental diam (z) 0.99 (0.86 to 1.13) −0.21 (−0.61 to 0.20) 0.48 (0.09 to 0.88)
P for trend 0.9 0.3 0.02
Placental area (z) 0.98 (0.86 to 1.13) −0.14 (−0.55 to 0.27) 0.47 (0.08 to 0.87)
P for trend 0.8 0.5 0.02
Tall mothers (HEIGHT > 160cm)
Birth weight (z) 1.11 (0.94 to 1.31) 0.21 (−0.29 to 0.71) 1.46 (0.95 to 1.97)
P for trend 0.2 0.4 <0.001
Ponderal index (z) 1.12 (0.96 to 1.32) 0.44 (−0.01 to 0.90) 0.47 (0.00 to 0.95)
P for trend 0.2 0.06 0.05
Placental weight (z) 1.06 (0.90 to 1.24) 0.01 (−0.47 to 0.49) 0.83 (0.33 to 1.32)
P for trend 0.5 1.0 0.001
Max placental diam (z) 1.06 (0.89 to 1.25) 0.12 (−0.39 to 0.62) 0.75 (0.23 to 1.28)
P for trend 0.5 0.6 0.005
Lesser placental diam (z) 1.18 (1.00 to 1.38) 0.58 (0.10 to 1.07) 0.65 (0.14 to 1.15)
P for trend 0.05 0.02 0.01
Placental area (z) 1.12 (0.95 to 1.32) 0.40 (−0.10 to 0.89) 0.71 (0.21 to 1.23)
P for trend 0.2 0.1 0.006
∗Odds ratios from multiple logistic regressions, including age and gender, with overweight as outcome.
+Coeﬃcients from multiple linear regressions, including age and gender, with body fat percent or lean body mass as outcome.
larger fatter lambs than would otherwise be. The association
between a large placental surface and later hypertension
depended on a large lesser diameter rather than a large
maximal diameter [11]. Our ﬁndings for overweight and
percentagebodyfataresimilarinthattheyareonlypredicted
by large lesser diameter. This is a further evidence that tissue
along the minor axis of the placental surface is qualitatively
diﬀerent to tissue along the major axis [25]. Tissue along the
minor axis may be more nutritionally sensitive.
We suggest that placental expansion increases the nutri-
entsupplytothefetus,butthissupplyisunbalanced.Wehave
previously proposed that compensatory placental expansion
increases glucose transfer to the fetus, but this may not be
matched by transfer of other nutrients, including proteins
[26, 27]. Glucose crosses the placenta by diﬀusion whereas
protein is actively transported. Placental enlargement could
aﬀect the fetus in the same way as high circulating maternal
glucose concentrations, initiating biochemical changes that
ultimately lead to obesity [4]. Our ﬁndings suggest that this
only occurs in people who are homozygotes for the Pro12
allele of the PPARγ2 gene. This allele is known to be linked
with insulin resistance [14–17].
4.1. Limitations of the Study. We have previously discussed
limitations of the Helsinki Birth Cohort Study [20, 21]. The
dataarerestrictedtosubjectswhowereborninHelsinkiUni-
versityCentralHospitalandattendedvoluntarychildwelfare
clinics, did not emigrate, and were still alive and willing to
participate in the year 2003. However, we believe that our
results, based on internal comparisons within the cohort, are
unlikely to diﬀer between those who attended and those who
didnot.Wehavenoinformationaboutwhataspectofmater-
nal malnutrition stimulated compensatory placental growth.
InFinland,asinothernorthernEuropeancountries,thelong
winters brought shortages of fruit and vegetables. In addi-
tion, there were widespread food shortages around the time
of the Second World War, when our cohort was born [28].
5. Conclusions
Wehavefoundthatalargeplacentalsurfaceareaisassociated
with a high body fat percentage and an increased risk of
being overweight in adult life. We suggest that the enlarged
surface is the result of expansion of the placental surface
to compensate for fetal malnutrition in midgestation. The
association between the placental surface area and adiposity
was only found in people with the Pro12Pro genotype of the
PPARγ2 gene. We suggest that there is an interplay between
nutritional factors and genes at the placental level, which is
aﬀecting the later risk for obesity.International Journal of Pediatrics 5
Table 4:Oddsratios(95%conﬁdenceinterval)foroverweightandregressioncoeﬃcientsforpercentbodyfatandleanbodymassinrelation
to birthweight and placental size, in the oﬀspring of tall mothers (height >160cm) who were carriers of the Pro12Pro genotype.
Overweight∗ Body fat (%)+ Lean body mass (kg)+
Birth weight (z) 1.20 (0.98 to 1.47) 0.41 (−0.19 to 1.01) 1.48 (0.87 to 2.09)
P for trend 0.08 0.2 <0.001
Ponderal index (z) 1.18 (0.97 to 1.43) 0.32 (−0.28 to 0.91) 0.61 (0.00 to 1.21)
P for trend 0.1 0.3 0.05
Placental weight (z) 1.18 (0.97 to 1.44) 0.28 (−0.31 to 0.87) 0.99 (0.39 to 1.60)
P for trend 0.1 0.4 0.001
Max placental diam (z) 1.28 (1.03 to 1.59) 0.51 (−0.14 to 1.16) 0.97 (0.30 to 1.64)
P for trend 0.02 0.1 0.005
Lesser placental diam (z) 1.34 (1.10 to 1.64) 0.85 (0.24 to 1.46) 1.03 (0.40 to 1.66)
P for trend 0.004 0.006 0.001
Placental area (z) 1.37 (1.10 to 1.71) 0.77 (0.12 to 1.42) 1.09 (0.42 to 1.75)
P for trend 0.005 0.02 0.001
Pro12Ala & Ala12Ala
Birth weight (z) 0.93 (0.68 to 1.28) −0.22 (−1.11 to 0.66) 1.41 (0.48 to 2.35)
P for trend 0.7 0.6 0.003
Ponderal index (z) 1.06 (0.81 to 1.40) 0.89 (0.18 to 1.61) 0.31 (−0.48 to 1.09)
P for trend 0.7 0.01 0.4
Placental weight (z) 0.85 (0.64 to 1.12) −0.56 (−1.37 to 0.24) 0.50 (−0.37 to 1.37)
P for trend 0.3 0.2 0.3
Max placental diam (z) 0.75 (0.56 to 0.99) −0.58 (−1.37 to 0.20) 0.41 (−0.44 to 1.26)
p for trend 0.04 0.1 0.3
Lesser placental diam (z) 0.88 (0.66 to 1.16) −0.05 (−0.84 to 0.73) −0.15 (−1.00 to 0.69)
P for trend 0.4 0.9 0.7
Placental area (z) 0.80 (0.61 to 1.04) −0.27 (−1.02 to 0.49) 0.12 (−0.69 to 0.93)
P for trend 0.1 0.5 0.8
∗Odds ratios from multiple logistic regressions, including age and gender, with overweight as outcome.
+Coeﬃcients from multiple linear regressions, including age and gender, with body fat percent or lean body mass as outcome.
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